Progenika makes DNA chip test for IBD (inflammatory bowel disease)
This article was originally published in Clinica
Executive Summary
Spanish firm Progenika is developing a DNA chip for optimising the diagnosis, prognosis and treatment of inflammatory bowel disease (IBD). Clinical trials for the product, called IBDChip, are expected to begin in May, the biotechnology company told Clinica.